Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
Industry representatives and anti-cannabis groups are challenging the federal rescheduling of marijuana following recent DEA hearings.
7 trends tracked about this subject — the full history, oldest to newest below.
Industry representatives and anti-cannabis groups are challenging the federal rescheduling of marijuana following recent DEA hearings.
Public skepticism grows regarding the Trump administration's commitment to federal marijuana rescheduling despite ongoing hearings and court challenges.
The Trump administration's shift in kratom policy sparks debate and scrutiny.
An investigation into a missing woman leads to the discovery of a chemical laboratory, weapons, and fake federal badges in an Olney home.
The DEA is facing scrutiny over transparency and witness testimony during hearings regarding the federal rescheduling of marijuana.
The DEA's upcoming marijuana rescheduling hearing is sparking debate and scrutiny across the cannabis industry.
The DEA is facing scrutiny after inviting only opponents of marijuana rescheduling to a hearing scheduled for June 29th.